Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (10): 46-50.doi: 10.6040/j.issn.1671-7554.0.2018.1035

Previous Articles    

Applications of digital PCR in cancer detection and treatment

GUAN Ming, ZHANG Xinju   

  1. Department of Central Laboratory, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China
  • Received:2018-09-04 Published:2022-09-27

PDF (PC)

185

Abstract: Digital PCR is a novel technique that facilitates the absolute quantitation of nucleic acid targets with high sensitivity. Digital PCR combined with liquid biopsies can be used in the detection of infinitesimal nucleic acid samples and rare mutations. It is particularly suitable for cancer patients who need repeated sampling. Digital PCR can provide adequate gene information in cancer diagnosis and relapse monitoring.

Key words: Digital PCR, Liquid biopsy, Genetic testing, Absolute quantitation, Cancer

CLC Number: 

  • R73-34
[1] Perkins G, Lu H, Garlan F, et al. Droplet-based digital PCR: application in cancer research[J]. Adv Clin Chem, 2017, 79: 43-91. doi: 10.1016/bs.acc.2016.10.001. Epub 2016 Dec 27.
[2] Alikian M, Gale RP, Apperley JF, et al. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia[J]. Biomol Detect Quantif, 2017, 11: 4-20. doi: 10.1016/j.bdq.2017.01.001. eCollection 2017 Mar.
[3] Yanagita M, Redig AJ, Paweletz CP, et al. A prospective evaluation of circulating tumor cells and cell-free DNA in EGFR-mutant non-small cell lung cancer patients treated with erlotinib on a phase II trial[J]. Clin Cancer Res, 2016, 22(24): 6010-6020.
[4] Hindson CM, Chevillet JR, Briggs HA, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR[J]. Nat Methods, 2013, 10(10): 1003-1005.
[5] 王晨, 李艳明, 方向东. 肿瘤液态活检的研究进展及其临床应用[J]. 遗传, 2017, 39(3): 220-231. WANG Chen, LI Yanming, FANG Xiangdong. Research progress on liquid biopsy in oncology and its clinical applications[J]. Hereditas, 2017, 39(3): 220-231.
[6] Chen WW, Balaj L, Liau LM, et al. BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles[J]. Mol Ther Nucleic Acids, 2013, 2: e109. doi:10.1038/mtna.2013.28
[7] Birkenkamp-Demtroder K, Nordentoft I, Christensen E, et al. Genomic alterations in liquid biopsies from patients with bladder cancer[J]. Eur Urol, 2016, 70(1): 75-82.
[8] Li N, Ma J, Guarnera MA, et al. Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer[J]. J Cancer Res Clin Oncol, 2014, 140(1): 145-150.
[9] Takahama T, Sakai K, Takeda M, et al. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors(West Japan oncology group 8014LTR study)[J]. Oncotarget, 2016, 7(36): 58492-58499.
[10] Diehl F, Schmidt K, Durkee KH, et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients[J]. Gastroenterology, 2008, 135(2): 489-498.
[11] Waterhouse M, Follo M, Pfeifer D, et al. Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR[J]. Ann Hematol, 2016, 95(5): 739-744.
[12] Shen J, Liao J, Guarnera MA, et al. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis[J]. J Thorac Oncol, 2014, 9(1): 33-40.
[13] Dodd DW, Gagnon KT, Corey DR. Digital quantitation of potential therapeutic target RNAs[J]. Nucleic Acid Ther, 2013, 23(3): 188-194.
[14] Ettinger DS, Wood DE, Akerley W, et al. Non-small cell lung cancer, version 6.2015[J]. J Natl Compr Canc Netw, 2015, 13(5): 515-524.
[15] Lee JY, Qing X, Xiumin W, et al. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: korean lung cancer consortium(KLCC-12-02)[J]. Oncotarget, 2016, 7(6): 6984-6993.
[16] Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med, 2004, 351(4): 337-345.
[17] Benson AR, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2017, 15(3): 370-398.
[18] Laurent-Puig P, Pekin D, Normand C, et al. Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy[J]. Clin Cancer Res, 2015, 21(5): 1087-1097.
[19] 张心菊, 关明. 高分辨熔解曲线分析在肿瘤分子检测中的应用[J]. 中华检验医学杂志, 2017,40(2): 80-83. ZHANG Xinjü, GUAN Ming. High-resolution melting analysis: applications in cancer detection[J]. Chinese Journal of Laboratory Medicine, 2017, 40(2): 80-83.
[20] Barault L, Amatu A, Bleeker FE, et al. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer[J]. Ann Oncol, 2015, 26(9): 1994-1999.
[21] Leto SM, Trusolino L. Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies[J]. J Mol Med(Berl), 2014, 92(7): 709-722.
[22] Bettoni F, Masotti C, Habr-Gama A, et al. Intratumoral genetic heterogeneity in rectal cancer: are single biopsies representative of the entirety of the tumor?[J]. Ann Surg, 2017, 265(1): e4-e6.
[23] Wang Z, Chen R, Wang S, et al. Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC[J]. PLoS One, 2014, 9(11): e110780. doi: 10.1371/journal.pone.0110780. eCollection 2014.
[24] Guttery DS, Page K, Hills A, et al. Noninvasive detection of activating estrogen receptor 1(ESR1)mutations in estrogen receptor-positive metastatic breast cancer[J]. Clin Chem, 2015, 61(7): 974-982.
[25] Goh HG, Lin M, Fukushima T, et al. Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay[J]. Leuk Lymphoma, 2011, 52(5): 896-904.
[26] 谭正兰. miR-221促进N-myc表达对神经母细胞瘤增殖的作用与机制研究[D]. 重庆: 重庆医科大学, 2016.
[27] Kurihara S, Ueda Y, Onitake Y, et al. Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors[J]. J Pediatr Surg, 2015, 50(12): 2094-2097.
[28] Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients[J]. Nat Rev Cancer, 2011, 11(6): 426-437.
[29] Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1): 12-19.
[30] Durst M, Hoyer H, Altgassen C, et al. Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status[J]. Oncotarget, 2015, 6(26): 23015-23025.
[31] Carow K, Read C, Hafner N, et al. A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients[J]. BMC Res Notes, 2017, 10(1): 532.
[32] Guibert N, Pradines A, Farella M, et al. Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma[J]. Lung Cancer, 2016, 100: 1-4. doi:10.1016/j.lungcan.2016.07.021.
[33] Olmedillas-Lopez S, Garcia-Arranz M, Garcia-Olmo D. Current and Emerging Applications of Droplet Digital PCR in Oncology[J]. Mol Diagn Ther, 2017, 21(5): 493-510.
[1] WU Ruifang, LI Changzhong. Status and progress of female fertility protection [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 1-7.
[2] LU Qun, ZHAO Lulu. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[3] LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46.
[4] HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118.
[5] XU Xiaofen, ZHU Xiao, MA Wei, LI Na. Influencing factors of cancer pain management disorder in 123 cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 119-124.
[6] FU Jia, WANG Lulu, HU Shuai, CHEN Zheping, LIU Dongyi, LI Qingsong, LU Guodong, ZHANG He, ZHAO Xin, FENG Chang. Effects of different approaches of quadrates lumborum block on postoperative recovery of patients undergoing radical gastrectomy [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 50-57.
[7] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[8] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[9] Qifeng YANG,Ning ZHANG. Sentinel lymph node biopsy of breast cancer in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5.
[10] WU Xinying, FENG Yiping, CHANG Kaifeng, JIA Xianjie, XUE Fuzhong. Causal association between green space and cancer incidence [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 115-119.
[11] QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82.
[12] WANG Fuli, SUN Yinping, QIN Jie, RONG Jiansheng. Efficacy of DC-CIK cells combined with EGFR-TKI for 35 elderly patients with advanced EGFR-mutant lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 110-117.
[13] BAO Shuqing, YANG Mingyue, LIU Duanrui, WANG Yunshan, JIA Yanfei. Role of NOX4 in ROS induction by Helicobacter pylori in gastric cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 19-25.
[14] WANG Jing, XIE Yan, LI Peilong, DU Lutao, WANG Chuanxin. Value of abnormal methylation of cg16212145 on GZMB gene in early screening of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 26-34.
[15] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd